As pharmaceutical, biotech, medical device, and diagnostics companies integrate into markets across the globe and partner across a wide geographic spectrum, there is growing need for services that see these industries from a holistic viewpoint. Guidehouse’s medical affairs team supports clients across a wide range of medical affairs needs within a wide range of markets, including Europe, the United States, Asia-Pacific, and the Middle East.

Our comprehensive medical affairs strategy can include

• Helping clients to understand their strategic and operational needs
• Defining areas of focus for the collaboration
• Partnering to co-create a medical affairs strategy
• Conducting a landscape and competitive intelligence evaluation for markets in question
• Assessing patients’ medical needs and developing patient journeys
• Mapping key stakeholders (nationally and internationally)
• Supporting organizational set-up
• Readying products for market

We offer seamless and integrated specialist services across the Medical Affairs function for diverse therapeutic areas covering prescription, medical devices, and over-the-counter products. Areas of expertise include:

• Medical strategic activities: Development of an integrated medical strategy for approved/licensed products and new molecular entities
• Medical communication: Publication planning and scientific/medical communications (including conference planning)
• Medical information: Development of standard response documents, evaluation of processes and training of internal and external teams
• Medical education: Support of HCP education and training of internal sales force and medical teams
• Medical research: Planning and execution of late-phase and real-world evidence studies
• Key Opinion Leader (KOL)/external expert activities: KOL/external expert mapping (nationally and internationally) and devising KOL activity trackers
• Medical field team (MSL) support: Regional mapping of MSL activities, developing key performance indicators (KPIs) and communication of scientific information through MSLs
• Digital Innovation: Supporting the implementation of machine learning and artificial intelligence (AI) to improve HCP interactions via digital platforms 

Download the Life Sciences Medical Affairs brochure